Although we did not formally prove that protection is dependent on CD4+ and CD8+ Trm, we have previously reported that protection using the B16-F10 melanoma model is highly dependent on CD8+ T cells, and in a lesser extent also on CD4+ T cells (52). The gene discussed is CD8A; the disease is melanoma.